Multiple Sclerosis Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People in the "exposed group": those who have received at least one dose of BRIUMVI® (ublituximab).
• People in the "unexposed group": those who have not received BRIUMVI® at any point during their pregnancy.
• People who have been diagnosed with multiple sclerosis (MS).
• People who are currently pregnant, or who have been pregnant within the last year.
• People whose healthcare provider has given permission for their data to be shared with the registry.

Who may not be able to join:

• People who, before enrolling, have been exposed to a category of medicines called anti-CD20 monoclonal antibodies (a type of MS treatment) at any point during the pregnancy (confirm with trial site).
• People whose pregnancy has already ended before they first make contact with the trial's virtual research coordination centre — meaning the trial does not enrol people after the pregnancy outcome has already occurred.
• People who have been exposed during pregnancy to medicines known to cause birth defects, or to any experimental/investigational medicines.

Important: Always verify eligibility with the trial site directly before applying.